Martin Steven Robert Insider Trades

Insider Trading History

Track insider trading activity for Martin Steven Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ensysce Biosciences
Ensysce Biosciences ENSC
Director
Holding Value $26.7k 100,850 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.64M 15,000 shares
$109.44
$0.26
Ensysce Biosciences
Ensysce Biosciences ENSC
Director
Holding Value $5.3k 20,000 shares
Last Trade
Feb 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.73M 20,000 shares
$386.40
$0.26
Ensysce Biosciences
Ensysce Biosciences ENSC
Director
Holding Value $17.5k 65,850 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$229M 65,850 shares
$3,477.60
$0.26
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Financial Officer
Holding Value $431k 56,000 shares
Last Trade
Mar 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$288k 56,000 shares
$5.14
$7.70
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Financial Officer
Holding Value $177k 23,000 shares
Last Trade
Dec 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.5k 23,000 shares
$3.15
$7.70
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Financial Officer
Holding Value $1.15M 149,362 shares
Last Trade
May 22, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$470k 149,362 shares
$3.15
$7.70
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Financial Officer
Holding Value $1.24M 161,290 shares
Last Trade
Apr 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$693k 161,290 shares
$4.30
$7.70
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Financial Officer
Holding Value $29k 3,760 shares
Last Trade
Dec 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.7k 3,760 shares
$4.45
$7.70
Armata Pharmaceuticals
Armata Pharmaceuticals ARMP
Chief Financial Officer
Holding Value $769k 99,919 shares
Last Trade
Jan 18, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 99,919 shares
$28.50
$7.70
Seelos Therapeutics
Seelos Therapeutics SEEL
Senior VP & CFO
Holding Value $26.3k 71,000 shares
Last Trade
Feb 20, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195B 71,000 shares
$2,747,246.26
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Senior VP & CFO
Holding Value $27.8k 75,000 shares
Last Trade
Feb 06, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204B 75,000 shares
$2,724,160.16
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Senior VP & CFO
Holding Value $7.4k 20,000 shares
Last Trade
May 23, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$122B 40,000 shares
$3,058,908.65
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Senior VP & CFO
Holding Value $507 1,371 shares
Last Trade
Mar 31, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.24B 1,371 shares
$3,093,537.81
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Interim CEO And CFO
Holding Value $925 2,500 shares
Last Trade
Feb 28, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.7B 2,500 shares
$3,081,994.76
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Interim CEO And CFO
Holding Value $925 2,500 shares
Last Trade
Jan 31, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.62B 2,500 shares
$3,047,365.60
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Interim CEO And CFO
Holding Value $925 2,500 shares
Last Trade
Dec 31, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.74B 2,500 shares
$2,297,067.25
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Interim CEO And CFO
Holding Value $27.8k 75,000 shares
Last Trade
Dec 18, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$176B 75,000 shares
$2,349,010.98
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Interim CEO & CFO
Holding Value $771 2,083 shares
Last Trade
Nov 30, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.29B 2,083 shares
$2,539,471.33
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Chief Financial Officer
Holding Value $72.2k 195,000 shares
Last Trade
Mar 05, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$727B 195,000 shares
$3,728,405.64
$0.37
Seelos Therapeutics
Seelos Therapeutics SEEL
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 02, 2011 Sale
$869B 150,000 shares
$5,794,611.86
$0.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up